Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 1998. Start Trial.
Date Value
November 12, 2026 1.732
November 11, 2026 1.764
November 10, 2026 1.747
November 09, 2026 1.716
November 06, 2026 1.668
November 05, 2026 1.589
November 04, 2026 1.610
November 03, 2026 1.585
November 02, 2026 1.564
October 30, 2026 1.595
October 29, 2026 1.608
October 28, 2026 1.572
October 27, 2026 1.568
October 26, 2026 1.532
October 23, 2026 1.508
October 22, 2026 1.548
October 21, 2026 1.546
October 20, 2026 1.562
October 19, 2026 1.530
October 16, 2026 1.563
October 15, 2026 1.526
October 14, 2026 1.461
October 13, 2026 1.445
October 12, 2026 1.469
October 09, 2026 1.478
Date Value
October 08, 2026 1.461
October 07, 2026 1.465
October 06, 2026 1.469
October 05, 2026 1.476
October 02, 2026 1.474
October 01, 2026 1.463
September 30, 2026 1.484
September 29, 2026 1.468
September 28, 2026 1.480
September 25, 2026 1.444
September 24, 2026 1.411
September 23, 2026 1.387
September 22, 2026 1.392
September 21, 2026 1.385
September 18, 2026 1.373
September 17, 2026 1.388
September 16, 2026 1.379
September 15, 2026 1.349
September 14, 2026 1.350
September 11, 2026 1.338
September 10, 2026 1.327
September 09, 2026 1.337
September 08, 2026 1.346
September 04, 2026 1.368
September 03, 2026 1.372

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Pacira Biosciences, Inc. 2.042
Pfizer Inc. 1.851
Eli Lilly & Co. 33.76
Merck & Co., Inc. 8.118
Amphastar Pharmaceuticals, Inc. 1.538

Price to Book Value Related Metrics